Lupus eritematoso sistémico: datos sociodemográficos y su correlación clínico-analítica en un hospital universitario
Resumen
Objetivos: analizar las características sociodemográficas y clínicas de los pacientes con Lupus Eritematoso Sistémico (LES) del Servicio de Reumatología de un Hospital Universitario de Córdoba.Citas
I. Pons Estel B, Alarcon G. Understanding the epidemiology and progression of SLE. Semin Arthritis Rheum. 2010;39:257-268.
II. Lu LJ, Wallace DJ. Review: Male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus. 2010;19:119-29.
III. Ballou SP, Khan MA, Kushner I. Clinical feactures of systemic lupus erytematosus: differences related to race and age of onset. Arthritis Rheum. 1982;25:55-60.
IV. Fernandez M, Alarcon G, Calvo-Alen J, Andrade R, Mc Gwin G, Vila LM, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematous as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007;57:576-84.
V. Pons-Estel B, Catoggio l, Soriana E, Gentiletti S, Villa A, et al. The GLADEL multinational latin American prospective incepcition cohort of 1214 patients with SLE: ethnic and disease heterogeneity among “Hispanics”. Medicine. 2004,83:1-17.
VI. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erytemathosus: role of race and socioeconomic status. The American journal of medicine. 1991;91:345-53.
VII. Callahan LP, Pincus T. Association between clinical status questionnaire scores and formal education level in persons with systemic lupus erythematosus. Arthritis Rheum. 1990;33:407-11.
VIII. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Archives of internal medicine.1990;150:849-53.
IX. Cervera R, font J. Carmona F. Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium. Autoimmun Rev. 2002,1:354-9.
X. Battagliotti CA, Kilstein J, Gentiletti AA, Pons Estel B. Lupus Eritematoso Sistémico. Aspectos clínicos y terapéuticos, Editorial Carlos Battagliotti, 2da Edic. 1998, p. 187-94.
XI. Petri M. La cohorte de Lupus de Hopkins. Puesta al día. Clínic Rheumatic Disease of North America (Edición Española). 2000; (2): 203-17.
XII. Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT. Mortality studies in systemic lupus erythematosus. Result from a single center. J. Rheumatol. 1997;24
XIII. Cronin ME. Musculoskeletal manifestations of lupus erthematosis: Rheum Dis North Am. 1988;14:99.
XIV. Paredes JG, Lazaro MA, Citera G, Maldonado Cocco J, 977. Jaccoud´s arthropathy of the hands in the overlaps syndrome. Clin Rheumatol, 1977;16(1):65-9.
XV. Anaya JM, Cervera R: Lupus eritematoso sistémico- Autoinmunidad y enfermedad autoinmune. Medellin. Corporacion para investigaciónes Biologicas. 2005; p. 255-73.
XVI. Marsol IB, Caruncho CR, Manifestaciones cutáneas del lupus eritematoso sistémico. Revisión. Inmunologia. 2010;29:100-110.
XVII. Saurit V, Campana R, Ruiz Lascano A, Ducasse C, Bertoli A, Aguero S, Alvarellos A, Caeiro F. Manifestaciones mucocutáneas en pacientes con lupus eritematoso sistémico. Medicina (Buenos Aires). 2003; 63:283-287.
XVIII. Menta Simone M, Constantino MA. Oral lesiones in lupus erythrmatosus: correlations con cutáneos lesión: Eur J Dermatol. 2008; 18(4):376-8.
XIX. Hamminga et al. Bulluos systemic Lupus erythematosus responding to mycophenolate mofetil. Eur J Dermatol 2010; Nov-Dec; 20(6):844-5.
XX. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 1990;150:849-53.
XXI. Lastra C, Mussano E, Cadile I, Onetti L. Detección de anomalías cardiovasculares en pacientes con lupus eritematoso sistémico mediante la utilización de ecocardiograma Doppler. Revista Argentina de Reumatología (SAR) Abstract Congreso Argentino SAR 2014, pag 55.
XXII. Roldan CA, Shively BK, Crawfort MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424-1430.
XXIII. Bruce IN, Urowitz MB, Gladman DD, Ibañez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk factor Study. Arthritis Rheum. 2003;48:3159-3167.
XXIV. Richer JG et al. Diagnostic algorithm for Raynaud`s phenomenom and vascular skin lesions in systemic lupus erythematosus. Lupus 2010;19:1087-1085.
XXV. Drenkard C, Villa AR, Reyes E, Abello, M, Alarcon Segovia D. Vasculitis in systemic lupus erythematosus. Lupus 1997;6:234-42.
XXVI. Caeiro F, Alvarellos A, Saurit V et al. Pleropulmonary compromise in systemic lupus erythematous of Latin American prospective inception cohort(Gladel). 9 International Congress of LES 2010. PO 1. C.20.
XXVII. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971;50(2):85-95.
XXVIII. Grigor R, Edmonds J, Lewkonia R, et al. Systemic lupus erythematosus: A prospective analysi. Ann Rheum Dis. 1978;37:121-8.
XXIX. Barile LA, Jara LJ, Medina-Rodriguez F et al. Pulmonary hemorrhage in systemic lupus erythematosus. Lupus 1997;6:445-8.
XXX. Arevalo JF, Lowder C, Muci-Mendoza R. Ocular manifestation of systemic lupus erythematosus.Curr Opinion in Ophtalmology 2002;13:404-410.
XXXI. Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology 1999;38:917-932.
XXXII. Mok CC. Investigations and management of gastrointestinal and hepatic maniofestations of systemic lupus erythematosus. Best Practice and Research Clinical Rheumatology.2005;19, 5:741-766.
XXXIII. Abraham S el al. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis. 2004;63:123-129.
XXXIV. Bonfa et al. Association between lupus and psychosis and antiribosomal P protein antibodies. N Engl J Med 1987;317:265-271.
XXXV. Shaye Kivity, Nancy Agmon-Levin, Gisele Zandman-Goddard, Joab Chapman and Yehuda Shoenfeld. Neuropsychiatric lupus: a mosaic of clinical presentations BMC Medicine 2015;13:43.
XXXVI. Fernandez M, Calvo-Alen J, Alarcón G y cols LUMINA, a multiethnic US Lupus Cohort. What have we learned? VITAE.ucv.ve
XXXVII. Andrade R, Sanchez M L, Alarcón G S, Fessler B J, Fernández M, Bertoli AM, Apte M, Vilá LM, Arango AM, Reveille J D; LUMINA Study Group. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a Multiethnic US cohort: LUMINA (LVI). Clin Exp Rheumatol. 2008 Mar-Apr;26(2):268-74.
XXXVIII. Cervera R, Font J. Carmona F. Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium. Autoimmun Rev. 2002,1:354-9.
XXXIX. Iñigo Rua-Figueroa, Celia Erausquin Factores asociados a la mortalidad del lupus eritematoso sistémico. Semin Fund Esp Reumatol. 2008;09:219-3413
XL. Schmid M et al. Manifestaciones y evolución clínica de pacientes con LES en un hospital de referencia. Revista Argentina de reumatología. 2013;24(1):28-32.
XLI. García M et al. Male systemic erythematosus in a Latin American inception cohort of 1214 patients. Lupus 2005. 14;938-946.
XLII. Pons Stel B et al. The GLADEL, multinational Latin American prospective inception cohort of 1214 patients with systemic lupus erythematosus: ethnic and disease heterogenecity among Hispanics. Medicine 2004;83;1-17.
XLIII. Alarcón G. Multiethnic lupus cohorts: What have they taught us? Reumatología clínica. 2011;7:3-6.
Derechos de autor 2019 Sociedad Argentina de Reumatología
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
